Hudson Bay Capital Management’s CureVac CVAC Stock Holding History

Hudson Bay Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,000	Closed	-$220K	–	1013
2021 Q2	$220K	Buy	+3,000	New	+$300K	﹤0.01%	840

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Hudson Bay Capital Management's CVAC Position: Q3 2021 in Review

Hudson Bay Capital Management sold out of CureVac (CVAC) in Q3 2021, closing a stake of 3,000 shares — an estimated $220K sold.

Hudson Bay Capital Management first reported a position in CVAC in Q2 2021 and held it in 1 quarter. The position peaked at $220K in Q2 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q3 2021.

Hudson Bay Capital Management reported no remaining CureVac position as of Q3 2021 after selling out during the quarter.
Hudson Bay Capital Management sold 3,000 CureVac shares in Q3 2021, an estimated $220K.
Hudson Bay Capital Management first reported a position in CureVac in Q2 2021 and held it in 1 quarter.
Hudson Bay Capital Management's CureVac position peaked at $220K in Q2 2021.
111 funds tracked by Wall St. Rank held CureVac as of Q3 2021.

Based on Hudson Bay Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.